Adhesion of human pathogenic enteric viruses and surrogate viruses to inert and vegetal food surfaces
Deboosere, N. Pinon, A. Caudrelier, Y. Delobel, A. Merle, G. Perelle, S. Temmam, S. Loutreul, J. Morin, T. Estienney, M. Belliot, G. Pothier, P. Gantzer, C. Vialette, M.
ORCID: 0000-0003-3655-9220
Characterization of viral communities of biting midges and identification of novel thogotovirus species and rhabdovirus genus 10.3390/v8030077
Screening for Viral Pathogens in African Simian Bushmeat Seized at A French Airport 10.1111/tbed.12481
Viral metagenomics: are we missing the giants? 10.1016/j.mib.2016.01.005
Faustovirus-like asfarvirus in hematophagous biting midges and their vertebrate hosts 10.3389/fmicb.2015.01406
Host-Associated metagenomics: A guide to generating infectious RNA Viromes 10.1371/journal.pone.0139810
First molecular detection of Rickettsia africae in ticks from the Union of the Comoros 10.1186/1756-3305-7-444
Viral metagenomics on animals as a tool for the detection of zoonoses prior to human infection? 10.3390/ijms150610377
Describing the silent human virome with an emphasis on giant viruses 10.1159/000354561
Development of real-time RT-PCR for the detection of low concentrations of Rift Valley fever virus 10.1016/j.jviromet.2013.10.001
High prevalence of hepatitis E in humans and pigs and evidence of genotype-3 virus in Swine, Madagascar 10.4269/ajtmh.2012.12-0615
Adhesion of human pathogenic enteric viruses and surrogate viruses to inert and vegetal food surfaces 10.1016/
Pathogenic leptospira spp. in bats, Madagascar and union of the comoros 10.3201/eid1810.111898
Influenza A(H1N1)pdm09 virus in pigs, Réunion Island. 10.3201/eid1810.120398
Intense Co-Circulation of Non-Influenza Respiratory Viruses during the First Wave of Pandemic Influenza pH1N1/2009: A Cohort Study in Reunion Island 10.1371/journal.pone.0044755
Identification of novel paramyxoviruses in insectivorous bats of the Southwest Indian Ocean 10.1016/j.virusres.2012.08.022
Molecular evolutionary analysis of pH1N1 2009 influenza virus in Reunion Island, South West Indian ocean region: A Cohort study 10.1371/journal.pone.0043742
Pandemic influenza due to pH1N1/2009 virus: Estimation of infection burden in Reunion Island through a prospective serosurvey, Austral Winter 2009 10.1371/journal.pone.0025738
Comparison of chlorine and peroxyacetic-based disinfectant to inactivate Feline calicivirus, Murine norovirus and Hepatitis A virus on lettuce 10.1016/j.ijfoodmicro.2011.08.011
Massilia virus, a novel phlebovirus (Bunyaviridae) isolated from sandflies in the Mediterranean 10.1089/vbz.2008.0131
Development and validation of real-time one-step reverse transcription-PCR for the detection and typing of dengue viruses 10.1016/j.jcv.2009.02.010
Sandfly fever sicilian virus, Algeria 10.3201/eid1405.071487
Cocirculation of 2 genotypes of Toscana virus, southeastern France 10.3201/eid1303.061086
A real-time RT-PCR method for the universal detection and identification of flaviviruses 10.1089/vbz.2007.0206
Long PCR Product Sequencing (LoPPS): A shotgun-based approach to sequence long PCR products 10.1038/nprot.2006.453
Alkhurma hemorrhagic fever virus in Ornithodoros savignyi ticks 10.3201/eid1301.061094
Toscana virus RNA in Sergentomyia minuta flies 10.3201/eid1708.060345
LoPPS: A long PCR product sequencing method for rapid characterisation of long amplicons 10.1016/j.bbrc.2006.04.015
A predictive microbiology approach for thermal inactivation of Hepatitis A virus in acidified berries 10.1016/
Virus zoonotiques et émergence : quels outils pour la surveillance ? 10.1684/vir.2016.0660
Un nouvel asfarvirus infectant des amibes découvert chez des arthropodes et leurs mammifères associés 10.1684/vir.2016.0661
Protocol for generating infectious RNA viromes from complex biological samples 10.1007/978-1-4939-8682-8_3
A novel polycipiviridae virus identified in pteropus lylei stools 10.1128/MRA.01662-18
Whole genome sequencing and phylogenetic characterization of a novel bat-associated picornavirus-like virus with an unusual genome organization 10.1016/j.meegid.2019.104130
RNA Viruses of Amblyomma variegatum and Rhipicephalus microplus and Cattle Susceptibility in the French Antilles 10.3390/v12020144
Viromics on Honey-Baited FTA Cards as a New Tool for the Detection of Circulating Viruses in Mosquitoes 10.3390/v12030274
Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus 10.1101/2020.04.07.029090
SARS-CoV-2 serological analysis of COVID-19 hospitalized patients, pauci-symptomatic individuals and blood donors 10.1101/2020.04.21.20068858
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations 10.1126/scitranslmed.abc3103
RVDB-prot, a reference viral protein database and its HMM profiles 10.12688/f1000research.18776.2
Deep Impact of Random Amplification and Library Construction Methods on Viral Metagenomics Results 10.3390/v13020253
Arterial abnormalities identified in kidneys transplanted into children during the COVID‐19 pandemic 10.1111/ajt.16464
Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020 10.2807/1560-7917.ES.2021.26.13.2001782
SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020 10.2807/1560-7917.ES.2021.26.15.2001695
The virome of Rhipicephalus , Dermacentor and Haemaphysalis ticks from Eastern Romania includes novel viruses with potential relevance for public health 10.1111/tbed.14105
Nathalie deboosere
deboosere Nathalie
ORCID: 0000-0002-2873-5485
ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton. 10.15252/embr.201744371
Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling. 10.1016/j.celrep.2017.08.101
A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone. 10.3390/toxins9070227
Phenotypic assays for Mycobacterium tuberculosis infection. 10.1002/cyto.a.23129
Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays. 10.1021/acschembio.7b00091
STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection. 10.1038/srep29297
LppM impact on the colonization of macrophages by Mycobacterium tuberculosis. 10.1111/cmi.12619
A microscopic phenotypic assay for the quantification of intracellular mycobacteria adapted for high-throughput/high-content screening. 10.3791/51114
Adhesion of human pathogenic enteric viruses and surrogate viruses to inert and vegetal food surfaces. 10.1016/
Viral elution and concentration method for detection of influenza A viruses in mud by real-time RT-PCR. 10.1016/j.jviromet.2011.10.013
Comparison of chlorine and peroxyacetic-based disinfectant to inactivate Feline calicivirus, Murine norovirus and Hepatitis A virus on lettuce. 10.1016/j.ijfoodmicro.2011.08.011
Direct detection of highly pathogenic avian influenza A/H5N1 virus from mud specimens. 10.1016/j.jviromet.2011.06.002
Development and validation of a concentration method for the detection of influenza a viruses from large volumes of surface water. 10.1128/aem.02484-10
A predictive microbiology approach for thermal inactivation of Hepatitis A virus in acidified berries. 10.1016/
Assessment of the removal and inactivation of influenza viruses H5N1 and H1N1 by drinking water treatment. 10.1016/j.watres.2010.01.013
Intra-laboratory validation of a concentration method adapted for the enumeration of infectious F-specific RNA coliphage, enterovirus, and hepatitis A virus from inoculated leaves of salad vegetables. 10.1016/j.ijfoodmicro.2005.11.007
Modelling effect of physical and chemical parameters on heat inactivation kinetics of hepatitis A virus in a fruit model system. 10.1016/j.ijfoodmicro.2003.10.015
Host-pathogen systems for early drug discovery against tuberculosis. 10.1016/j.mib.2017.11.017
Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids. 10.1073/pnas.1707840114
Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis. 10.1038/s41598-017-11843-4
Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages. 10.1016/j.chom.2017.07.020
Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles. 10.1038/s41598-017-05453-3
Host-directed therapies offer novel opportunities for the fight against tuberculosis. 10.1016/j.drudis.2017.05.005
Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs. 10.1016/j.ijpharm.2017.05.030
Impact of pe_pgrs33 Gene Polymorphisms on Mycobacterium tuberculosis Infection and Pathogenesis. 10.3389/fcimb.2017.00137
Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections. 10.2217/nnm-2016-0364
Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420. 10.1126/science.aag1006
How can nanoparticles contribute to antituberculosis therapy? 10.1016/j.drudis.2017.01.011
Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism. 10.1007/s00401-016-1652-z
Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria. 10.1111/mmi.13535
Mycobacterium tuberculosis LppM Displays an Original Structure and Domain Composition Linked to a Dual Localization. 10.1016/j.str.2016.07.009
Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro. 10.1007/s00705-016-2771-5
[Mycolactone: the amazing analgesic mycobacterial toxin]. 10.1051/medsci/20163202007
A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters. 10.1039/c5ob02630j
Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action. 10.1128/jvi.01473-15
Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro. 10.3389/fmicb.2015.00488
Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system. 10.1016/j.vaccine.2015.03.083
Cytosolic access of Mycobacterium tuberculosis: critical impact of phagosomal acidification control and demonstration of occurrence in vivo. 10.1371/journal.ppat.1004650
[High content screening in chemical biology: overview and main challenges]. 10.1051/medsci/20153102016
Testing chemical and genetic Modulators in Mycobacterium tuberculosis infected cells using phenotypic assays. 10.1007/978-1-4939-2450-9_24
2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1. 10.1021/cb5007163
High-content screening technology combined with a human granuloma model as a new approach to evaluate the activities of drugs against Mycobacterium tuberculosis. 10.1128/aac.03705-14
Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways. 10.1016/j.cell.2014.04.040
Ligand efficiency driven design of new inhibitors of Mycobacterium tuberculosis transcriptional repressor EthR using fragment growing, merging, and linking approaches. 10.1021/jm500422b
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. 10.1038/nm.3262
The balance of apoptotic and necrotic cell death in Mycobacterium tuberculosis infected macrophages is not dependent on bacterial virulence. 10.1371/journal.pone.0047573
Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis. 10.1021/jm300377g
Ethionamide boosters. 2. Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitors. 10.1021/jm200825u
A novel specific edge effect correction method for RNA interference screenings. 10.1093/bioinformatics/btr648
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis. 10.1371/journal.pone.0026675
High-content screening in infectious diseases. 10.1016/j.cbpa.2011.05.023
Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors. 10.1021/jm200076a
Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease. 10.1186/1753-6561-5-s1-p38
High content phenotypic cell-based visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodeling. 10.1371/journal.ppat.1001100
High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery. 10.4155/fmc.10.223
Functional characterization of the Mycobacterium tuberculosis serine/threonine kinase PknJ. 10.1099/mic.0.038133-0
High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors. 10.1371/journal.ppat.1000645
Systematic genetic nomenclature for type VII secretion systems. 10.1371/journal.ppat.1000507
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. 10.1016/j.biomaterials.2009.09.044
Automated HTS/HCS for antivirals using visual HIV full replication assays. 10.1186/1742-4690-6-s2-p82
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. 10.1126/science.1171583
Automated high-throughput siRNA transfection in raw 264.7 macrophages: a case study for optimization procedure. 10.1177/1087057108328762
Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP. 10.1371/journal.ppat.0040033
ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. 10.1128/jb.00469-07
[Aquatic insects and transmission of Mycobacterium ulcerans]. 10.1051/medsci/20072367572
Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. 10.1371/journal.ppat.0030062
Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva. 10.1371/journal.pmed.0040064
Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues. 10.1016/j.bmc.2006.12.009
Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence. 10.1128/jb.00631-06
High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection. 10.1128/iai.02086-05
Benzofuro[3,2-f][1]benzopyrans: a new class of antitubercular agents. 10.1016/j.bmc.2006.03.033
An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis. 10.1128/iai.74.4.2128-2137.2006
Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. 10.1128/iai.74.1.88-98.2006
Tuberculosis: from genome to vaccine. 10.1586/14760584.4.4.541
Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity. 10.1074/jbc.m503515200
Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics. 10.1099/mic.0.27799-0
Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. 10.4049/jimmunol.174.6.3570
Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis. 10.1016/
ESAT-6 proteins: protective antigens and virulence factors? 10.1016/j.tim.2004.09.007
Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens. 10.1086/421468
Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6. 10.1128/iai.72.4.2170-2176.2004
Macro-array and bioinformatic analyses reveal mycobacterial 'core' genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex. 10.1099/mic.0.26662-0
CD8+-T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family. 10.1128/iai.71.12.7173-7177.2003
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. 10.1038/nm859
Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. 10.1046/j.1365-2958.2002.03237.x
Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant. 10.1128/iai.70.10.5568-5578.2002
Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides. 10.1021/bi015732y
IRG1 controls immunometabolic host response and restricts intracellular Mycobacterium tuberculosis infection 10.1101/761551
Large scale screening discovers clofoctol as an inhibitor of SARS-CoV-2 replication that reduces COVID-19-like pathology 10.1101/2021.06.30.450483
ORCID: 0000-0003-1161-9530
Vomiting symptom of acute gastroenteritis estimated from epidemiological data can help predict river contamination by human pathogenic enteric viruses. 10.1016/j.envint.2018.11.058
A Biocatalytic Nanomaterial for the Label-Free Detection of Virus-Like Particles. 10.1002/cbic.201700126
HS-AFM and SERS Analysis of Murine Norovirus Infection: Involvement of the Lipid Rafts. 10.1002/smll.201600918
Cosavirus, Salivirus and Bufavirus in Diarrheal Tunisian Infants. 10.1371/journal.pone.0162255
Rotavirus P[8] Infections in Persons with Secretor and Nonsecretor Phenotypes, Tunisia. 10.3201/eid2111.141901
Relationship between GII.3 norovirus infections and blood group antigens in young children in Tunisia. 10.1016/j.cmi.2015.05.015
Evidence for human norovirus infection of dogs in the United kingdom. 10.1128/JCM.02778-14
Virus-like particles as virus substitutes to design artificial virus-recognition nanomaterials. 10.1039/c4cc08843c
Norovirus and rotavirus survival in urine collected from a public ecological sanitation system in Ouagadougou, Burkina Faso. 10.1007/s12560-014-9172-2
Absolute Humidity Influences the Seasonal Persistence and Infectivity of Human Norovirus. 10.1128/AEM.01871-14
The burden of norovirus gastroenteritis: an important foodborne and healthcare-related infection. 10.1111/1469-0691.12722
Noroviruses and histo-blood groups: the impact of common host genetic polymorphisms on virus transmission and evolution. 10.1002/rmv.1757
Reverse Genetics System for Porcine Enteric Calicivirus, a Prototype Sapovirus in the Caliciviridae. 10.1128/JVI.01364-13
Potential of Pulsed Light to Inactivate Bacteriophage MS2 in Simple Liquid Medium and on Complex Foodstuffs. 10.1007/s12560-013-9110-8
Adhesion of human pathogenic enteric viruses and surrogate viruses to inert and vegetal food surfaces. 10.1016/
Selection of a phylogenetically informative region of the norovirus genome for outbreak linkage. 10.1007/s11262-011-0673-x
Presence of enteric hepatitis viruses in the sewage and population of Greater Cairo. 10.1111/j.1469-0691.2011.03461.x
An integrated approach to identifying international foodborne norovirus outbreaks. 10.3201/eid1703.100979
Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens. 10.1128/JVI.02077-10
Use of norovirus genotype profiles to differentiate origins of foodborne outbreaks. 10.3201/eid1604.090723
[Norovirus infections: an overview]. 10.1051/medsci/201026173
Evidence of emergence of new GGII.4 norovirus variants from gastroenteritis outbreak survey in France during the 2007-to-2008 and 2008-to-2009 winter seasons. 10.1128/JCM.01888-09
Evidence of the co-circulation of enteric viruses in sewage and in the population of Greater Cairo. 10.1111/j.1365-2672.2009.04562.x
Predominance and circulation of enteric viruses in the region of Greater Cairo, Egypt. 10.1128/JCM.01381-08
Selection tool for foodborne norovirus outbreaks. 10.3201/eid1501.080673
Use of murine norovirus as a surrogate to evaluate resistance of human norovirus to disinfectants. 10.1128/AEM.02148-07
Nucleotidylylation of the VPg protein of a human norovirus by its proteinase-polymerase precursor protein. 10.1016/j.virol.2007.12.028
Cleavage map and proteolytic processing of the murine norovirus nonstructural polyprotein in infected cells. 10.1128/JVI.00532-06
Stable expression of a Norwalk virus RNA replicon in a human hepatoma cell line. 10.1016/j.virol.2006.06.006
Pathology of immunodeficient mice with naturally occurring murine norovirus infection. 10.1080/01926230600918876
Feline calicivirus VP2 is essential for the production of infectious virions. 10.1128/JVI.79.7.4012-4024.2005
Norovirus proteinase-polymerase and polymerase are both active forms of RNA-dependent RNA polymerase. 10.1128/JVI.79.4.2393-2403.2005
Enteroviruses 76, 89, 90 and 91 represent a novel group within the species Human enterovirus A. 10.1099/vir.0.80475-0
Reverse genetics system for porcine enteric calicivirus, a prototype sapovirus in the Caliciviridae. 10.1128/JVI.79.3.1409-1416.2005
Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages. 10.1371/journal.pbio.0020432
Calicivirus 3C-like proteinase inhibits cellular translation by cleavage of poly(A)-binding protein. 10.1128/JVI.78.15.8172-8182.2004
Bile acids are essential for porcine enteric calicivirus replication in association with down-regulation of signal transducer and activator of transcription 1. 10.1073/pnas.0401126101
Norwalk virus N-terminal nonstructural protein is associated with disassembly of the Golgi complex in transfected cells. 10.1128/JVI.78.9.4827-4837.2004
In vitro proteolytic processing of the MD145 norovirus ORF1 nonstructural polyprotein yields stable precursors and products similar to those detected in calicivirus-infected cells. 10.1128/JVI.77.20.10957-10974.2003
Feline calicivirus replication induces apoptosis in cultured cells. 10.1016/s0168-1702(03)00115-1
Development of a rapid method using nucleic acid sequence-based amplification for the detection of astrovirus. 10.1016/s0166-0934(03)00108-3
Isolation of enzymatically active replication complexes from feline calicivirus-infected cells. 10.1128/JVI.76.17.8582-8595.2002
A predominant role for Norwalk-like viruses as agents of epidemic gastroenteritis in Maryland nursing homes for the elderly. 10.1086/338365
Characterization of capsid genes, expressed in the baculovirus system, of three new genetically distinct strains of "Norwalk-like viruses". 10.1128/JCM.39.12.4288-4295.2001
Characterization of "Norwalk-like viruses" and astroviruses by liquid hybridization assay. 10.1016/s0166-0934(00)00254-8
RT-PCR identification and typing of astroviruses and Norwalk-like viruses in hospitalized patients with gastroenteritis: evidence of nosocomial infections. 10.1016/s1386-6532(00)00088-3
The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics. 10.1086/315588
[Prevention of rotavirus diarrhea by vaccination]. 10.1016/s0929-693x(99)80455-2
Localization of neurotrophin-3-like immunoreactivity in the rat cochlear nucleus. 10.1002/(sici)1097-0029(19980501)41:3<224::aid-jemt6>;2-t
Capsid protein composition of reference strains and wild isolates of human astroviruses. 10.1016/s0168-1702(97)01457-3
Outbreak of gastroenteritis in military recruits associated with serotype 3 astrovirus infection. 10.1002/(sici)1096-9071(199702)51:2<101::aid-jmv3>;2-b
Detection and genetic differentiation of human astroviruses: phylogenetic grouping varies by coding region. 10.1007/s007050050163